Advocacy intelligence hub — real-time data for patient organizations
Didronel: FDA approved
Treatment of hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Didronel
MGI Pharma, Inc.
Didronel
(Etidronate disodium)Orphan drugMGI Pharma, Inc.
Browse all Disorder of peroxisomal alpha-, beta- and omega-oxidation news →
View all Disorder of peroxisomal alpha-, beta- and omega-oxidation specialists →